Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02681341 · ClinicalTrials.gov registry record

Vascular Post Market Review

A clinical trial, sponsored by Baylor Research Institute.

Completed
Registry status
10
Enrollment target

NCT02681341 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02681341 has completed, sponsored by Baylor Research Institute.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2016-02
Est. Completion 2017-09-21

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT02681341

The ClinicalTrials.gov registry entry for NCT02681341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02681341 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02681341 about?

NCT02681341 is a clinical study titled "Vascular Post Market Review". The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.

What is the current status of trial NCT02681341?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2017-09-21.

Who is sponsoring clinical trial NCT02681341?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.